Brief: Todos Medical Says Distribution Agreement With Adial Pharmaceuticals To Market FDA, Eua Authorized, Assure/Fastep Point-Of-Care Covid-19 Antibody Tests
22/10/2020 15:58
Oct 22 (Reuters) - TODOS MEDICAL:
* TODOS MEDICAL - DISTRIBUTION AGREEMENT WITH ADIAL
PHARMACEUTICALS TO MARKET FDA, EUA AUTHORIZED, ASSURE/FASTEP
POINT-OF-CARE COVID-19 ANTIBODY TESTS
Source text for Eikon: ID:nGNX2rJtx4
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Todos Medical
See all newsBrief: Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network
Brief: Todos Medical Clia/Cap Lab Provista Submits Emergency Use Authorization Application For Monkeypox Pcr Test To Us FDA
Brief: Todos Medical Provides Corporate Update
Brief: Todos Medical Enters Into $50 Mln Contract To Supply Tollovid, CBD Products To Retail Distributor Company Nerd Hemp
Brief: Todos Medical Establishes Botanical Supplement Manufacturing Capabilities